Edward Mitre1, Daniel Chien, Thomas B Nutman. 1. Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. emitre@usuhs.mil
Abstract
BACKGROUND: Interleukin (IL)-10 plays an important role in down-regulating the immune response to filarial parasites. The goal of this study was to characterize the predominant cellular source of IL-10 in human filarial infections. METHODS: Multicolor flow cytometry was used to determine the frequencies of IL-10 production from various lymphocyte populations in the circulation of 23 patients with filarial infections and 8 uninfected control subjects. RESULTS: The frequencies of cells spontaneously producing IL-10 was significantly greater in filaria-infected patients than in uninfected control subjects (geometric mean, 93 vs. 18 IL-10-producing cells/100,000 peripheral blood mononuclear cells; P = .03). Most IL-10-producing cells in filaria-infected patients were T cells, with CD4(+) and CD8(+) cells accounting for 48% and 27%, respectively, of all IL-10-producing cells; CD19(+) B cells, CD14(+) monocytes, and CD56(+) NK cells accounted for 10%, 8%, and 7%, respectively. Surprisingly, only 12% of the IL-10-producing CD3(+)CD4(+) cells were CD25(+). Seventy-seven percent of IL-10-producing CD4(+) T cells stained negatively for both IL-4 and interferon (IFN)-gamma, 22% were positive for IL-4, and <1% were positive for IFN-gamma. CONCLUSIONS: These experiments demonstrate that the most frequent producers of IL-10 in human filarial infections are CD4(+) T cells, many of which are skewed toward a type 2 phenotype and most of which are not CD25(+).
BACKGROUND:Interleukin (IL)-10 plays an important role in down-regulating the immune response to filarial parasites. The goal of this study was to characterize the predominant cellular source of IL-10 in humanfilarial infections. METHODS: Multicolor flow cytometry was used to determine the frequencies of IL-10 production from various lymphocyte populations in the circulation of 23 patients with filarial infections and 8 uninfected control subjects. RESULTS: The frequencies of cells spontaneously producing IL-10 was significantly greater in filaria-infectedpatients than in uninfected control subjects (geometric mean, 93 vs. 18 IL-10-producing cells/100,000 peripheral blood mononuclear cells; P = .03). Most IL-10-producing cells in filaria-infectedpatients were T cells, with CD4(+) and CD8(+) cells accounting for 48% and 27%, respectively, of all IL-10-producing cells; CD19(+) B cells, CD14(+) monocytes, and CD56(+) NK cells accounted for 10%, 8%, and 7%, respectively. Surprisingly, only 12% of the IL-10-producing CD3(+)CD4(+) cells were CD25(+). Seventy-seven percent of IL-10-producing CD4(+) T cells stained negatively for both IL-4 and interferon (IFN)-gamma, 22% were positive for IL-4, and <1% were positive for IFN-gamma. CONCLUSIONS: These experiments demonstrate that the most frequent producers of IL-10 in humanfilarial infections are CD4(+) T cells, many of which are skewed toward a type 2 phenotype and most of which are not CD25(+).
Authors: Simon Metenou; Benoit Dembele; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Sekou F Traoré; Siddhartha Mahanty; Amy Klion; Thomas B Nutman Journal: J Immunol Date: 2010-03-31 Impact factor: 5.422
Authors: Simon Metenou; Benoit Dembélé; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Marissa Wagner; Sekou F Traoré; Amy Klion; Siddhartha Mahanty; Thomas B Nutman Journal: J Immunol Date: 2009-06-26 Impact factor: 5.422
Authors: David Larson; Marc P Hübner; Marina N Torrero; Christopher P Morris; Amy Brankin; Brett E Swierczewski; Stephen J Davies; Becky M Vonakis; Edward Mitre Journal: J Immunol Date: 2012-03-28 Impact factor: 5.422
Authors: Pedro H Gazzinelli-Guimarães; Sandra Bonne-Année; Ricardo T Fujiwara; Helton C Santiago; Thomas B Nutman Journal: J Immunol Date: 2016-08-26 Impact factor: 5.422